Linezolid and the risk of QT interval prolongation: A pharmacovigilance study of the Food and Drug Administration Adverse Event Reporting System.

Haixia ShaoDa-Wei ShiYing Dai

Published in: British journal of clinical pharmacology (2022)

The study showed an association between LZD and QT interval prolongation. In the report on patients with tuberculosis, the incidence of QTp was higher when treated with LZD.

Keyphrases

drug induced
adverse drug
drug administration
risk factors
staphylococcus aureus
hepatitis c virus
human immunodeficiency virus
hiv aids